Çѱ¹ÀÎ Àü¸³¼±¾ÏÀÇ ÀÓ»ó º´¸®ÇÐÀû Ư¡ ¹× ÀÓ»óÀû ±¹¼Ò Àü¸³¼±¾Ï¿¡ ´ëÇÑ º´¸®ÇÐÀû º´±âÀÇ ¿¹Ãø ³ë¸ð±×·¥: ´Ù±â°ü ¿¬±¸
Clinico-pathological Characteristics of Prostate Cancer in Korean Men and Nomograms for the Prediction of the Pathological Stage of the Clinically Localized Prostate Cancer: A Multi-institutional Update
¼Û丰, °ÅÂÁø, À̹«¼º, ³ëÀçÀ±, ÀÌ»óÀº, ÀÌÀº½Ä, ÃÖÇÑ¿ë, ÇÑ´öÇö, È«¼ºÁØ, Á¤º´ÇÏ, ±èû¼ö, ¾ÈÇÑÁ¾,
¼Ò¼Ó »ó¼¼Á¤º¸
¼Û丰 ( Song Cheryn )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
°ÅÂÁø ( Kang Tae-jin )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
À̹«¼º ( Lee Moo-Song )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç
³ëÀçÀ± ( Ro Jae Y. )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÌ»óÀº ( Lee Sang-Eun )
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÀÌÀº½Ä ( Lee Eun-Sik )
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÃÖÇÑ¿ë ( Choi Han-Yong )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÇÑ´öÇö ( Han Deok-Hyun )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
È«¼ºÁØ ( Hong Sung-Joon )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç, ºñ´¢ÀÇ°úÇבּ¸¼Ò
Á¤º´ÇÏ ( Chung Byung-Ha )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç, ºñ´¢ÀÇ°úÇבּ¸¼Ò
±èû¼ö ( Kim Choung-Soo )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
¾ÈÇÑÁ¾ ( Ahn Han-Jong )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
KMID : 0358320070480020125
Abstract
Purpose: In this multi institutional study, the data of 604 men with clinically localized prostate cancer, who underwent radical prostatectomy, with updated nomograms predicting the pathological stage, were analyzed.
Materials & Methods: Prostate biopsies and prostatectomy specimens from men treated with radical prostatectomy, obtained between 1990 and 2003, were included. The patient distribution with respect to clinical stage, serum prostate-specific antigen(PSA) and biopsy Gleason score, as well as final pathological findings, including organ-confined disease(OCD), extracapsular extension(ECE), seminal vesicle invasion(SVI), and lymph node metastasis(LNM), were analyzed for the construction of nomograms representing the percent probabilities of each respective pathological outcome.
Results: The median serum PSA at the time of surgery and biopsy Gleason score were 9.9ng/ml and 7, respectively. The preoperative serum PSA was 4ng/ml or less in 38(6.3%) patients and the tumor was impalpable in 292 (48.2%) of patients. The biopsy Gleason scores were 7 and 8 or higher in 186(30.7%) and 169(27.9%), respectively. Throughout the clinical stages and PSA ranges, the Gleason score was 7 or higher in more than 50% of patients, but 8-10 in 20-30%. The overall OCD, ECE, SVI and LNM rates were 57.1, 27.8, 10.9 and 4.2%, respectively.
Conclusion: A significantly high proportion of prostate cancers arising in Korean men exhibited poor differentiation, with Gleason scores of 7 or higher, regardless of the clinical stage or initial serum PSA. Updated nomograms acknowledging such characteristics have been developed, which may aid in the treatment planning of these individuals. (Korean J Urol 2007;48:125-130)
Å°¿öµå
Prostate neoplasm;Prostatectomy;Nomograms
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸